Patent ID: 11913051
Assignee: LIMMATECH BIOLOGICS AG
Field: Biotechnology (Chemistry)
Classification: CPC C | IPC C

Claim 8:
9. The host cell of claim 4, wherein the CMP-Sia biosynthetic pathway proteins capable of generating CMP-NeuAc are at least about 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% identical to CMP-Sia biosynthetic pathway proteins selected from the group consisting of GNE, GNE/MNK, GNE/MNK mutated with either a R263L or R263Q, NANS, NANP, CST, neuA, neuC, neuB, GNPE, or CgNal, or any functional homologue, isoform or variant thereof.